For all cancers, a comparison of tumor and healthy tissue samples revealed significant SST hypermethylation in tumor (Fig. 4C), implying that SST hypermethylation is a general and common feature in a broad range of tumors and could be utilized as a pan‐cancer biomarker. This evidence concerns the gene SST and neoplasm.